Skip to main content

High-throughput genomic technology in research and clinical management of breast cancer

Yudi Pawitan, Per Hall

  1. Protein-based breast cancer biomarkers are a promising resource for breast cancer detection at the earliest and most treatable stages of the disease. Plasma is well suited to proteomic-based methods of biomark...

    Authors: Michael A Davis and Samir Hanash
    Citation: Breast Cancer Research 2006 8:217
  2. Gene expression profiling is a relatively new technology for the study of breast cancers, but within the past few years there has been a rapid rise in interest in its potential to improve the clinical manageme...

    Authors: Andrew H Sims, Kai Ren Ong, Robert B Clarke and Anthony Howell
    Citation: Breast Cancer Research 2006 8:214
  3. It is generally accepted that early detection of breast cancer has great impact on patient survival, emphasizing the importance of early diagnosis. In a widely recognized model of breast cancer development, tu...

    Authors: Karin Rennstam and Ingrid Hedenfalk
    Citation: Breast Cancer Research 2006 8:213
  4. Candidate polymorphism-based genetic epidemiological studies have yielded little success in the search for low-penetrance breast cancer susceptibility genes. The lack of progress is partially due to insufficie...

    Authors: Yen-Ling Low, Sara Wedrén and Jianjun Liu
    Citation: Breast Cancer Research 2006 8:209